Research ArticleRheumatoid Arthritis
Open Access
Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality
Karina Raimundo, Joshua J. Solomon, Amy L. Olson, Amanda M. Kong, Ashley L. Cole, Aryeh Fischer and Jeffrey J. Swigris
The Journal of Rheumatology April 2019, 46 (4) 360-369; DOI: https://doi.org/10.3899/jrheum.171315
Karina Raimundo
From Genentech Inc., South San Francisco, California; National Jewish Health, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; University of Colorado School of Medicine, Denver, Colorado,
USA.
Joshua J. Solomon
Amy L. Olson
Amanda M. Kong
Ashley L. Cole
Aryeh Fischer
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 46, Issue 4
1 Apr 2019
Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality
Karina Raimundo, Joshua J. Solomon, Amy L. Olson, Amanda M. Kong, Ashley L. Cole, Aryeh Fischer, Jeffrey J. Swigris
The Journal of Rheumatology Apr 2019, 46 (4) 360-369; DOI: 10.3899/jrheum.171315
Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality
Karina Raimundo, Joshua J. Solomon, Amy L. Olson, Amanda M. Kong, Ashley L. Cole, Aryeh Fischer, Jeffrey J. Swigris
The Journal of Rheumatology Apr 2019, 46 (4) 360-369; DOI: 10.3899/jrheum.171315